These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. Limper AH; Hoyte JS; Standing JE J Clin Invest; 1997 May; 99(9):2110-7. PubMed ID: 9151783 [TBL] [Abstract][Full Text] [Related]
43. Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia. Nandakumar V; Hebrink D; Jenson P; Kottom T; Limper AH Infect Immun; 2017 Mar; 85(3):. PubMed ID: 27993972 [TBL] [Abstract][Full Text] [Related]
45. Pneumocystis pneumonia increases the susceptibility of mice to sublethal hyperoxia. Beck JM; Preston AM; Wilcoxen SE; Morris SB; White ES; Paine R Infect Immun; 2003 Oct; 71(10):5970-8. PubMed ID: 14500517 [TBL] [Abstract][Full Text] [Related]
46. Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages. Zhang J; Zhu J; Bu X; Cushion M; Kinane TB; Avraham H; Koziel H Mol Biol Cell; 2005 Feb; 16(2):824-34. PubMed ID: 15574879 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice. Beers MF; Atochina EN; Preston AM; Beck JM J Lab Clin Med; 1999 May; 133(5):423-33. PubMed ID: 10235125 [TBL] [Abstract][Full Text] [Related]
48. All-trans retinoic acid in combination with primaquine clears pneumocystis infection. Lei GS; Zhang C; Shao S; Jung HW; Durant PJ; Lee CH PLoS One; 2013; 8(1):e53479. PubMed ID: 23308231 [TBL] [Abstract][Full Text] [Related]
49. Therapeutic efficacies of chitosan against Pneumocystis pneumonia of immunosuppressed rat. Liu AB; Pu Y; Zheng YQ; Cai H; Ye B Parasite Immunol; 2014 Jul; 36(7):292-302. PubMed ID: 24702055 [TBL] [Abstract][Full Text] [Related]
50. Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina. Kelly MN; Zheng M; Ruan S; Kolls J; D'Souza A; Shellito JE J Immunol; 2013 Jan; 190(1):285-95. PubMed ID: 23203926 [TBL] [Abstract][Full Text] [Related]
51. CD4(+) T-Cell-Independent Secondary Immune Responses to Pneumocystis Pneumonia. de la Rua NM; Samuelson DR; Charles TP; Welsh DA; Shellito JE Front Immunol; 2016; 7():178. PubMed ID: 27242785 [TBL] [Abstract][Full Text] [Related]
52. Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia. McKinley L; Logar AJ; McAllister F; Zheng M; Steele C; Kolls JK J Immunol; 2006 Nov; 177(9):6215-26. PubMed ID: 17056551 [TBL] [Abstract][Full Text] [Related]
53. Pneumocystis infection alters the activation state of pulmonary macrophages. Deckman JM; Kurkjian CJ; McGillis JP; Cory TJ; Birket SE; Schutzman LM; Murphy BS; Garvy BA; Feola DJ Immunobiology; 2017 Feb; 222(2):188-197. PubMed ID: 27720434 [TBL] [Abstract][Full Text] [Related]
54. Pneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages. Liao CP; Lasbury ME; Wang SH; Zhang C; Durant PJ; Murakami Y; Matsufuji S; Lee CH J Biol Chem; 2009 Mar; 284(12):8174-84. PubMed ID: 19158080 [TBL] [Abstract][Full Text] [Related]
55. PTEN limits alveolar macrophage function against Pseudomonas aeruginosa after bone marrow transplantation. Hubbard LL; Wilke CA; White ES; Moore BB Am J Respir Cell Mol Biol; 2011 Nov; 45(5):1050-8. PubMed ID: 21527775 [TBL] [Abstract][Full Text] [Related]
56. A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progression. Qureshi MH; Garvy BA; Pomeroy C; Inayat MS; Oakley OR Virus Res; 2005 Dec; 114(1-2):35-44. PubMed ID: 16002171 [TBL] [Abstract][Full Text] [Related]
57. Pneumocystis carinii: an atypical fungal micro-organism. Cailliez JC; Séguy N; Denis CM; Aliouat EM; Mazars E; Polonelli L; Camus D; Dei-Cas E J Med Vet Mycol; 1996; 34(4):227-39. PubMed ID: 8873881 [TBL] [Abstract][Full Text] [Related]
58. Role of type I IFNs in pulmonary complications of Pneumocystis murina infection. Meissner NN; Swain S; Tighe M; Harmsen A; Harmsen A J Immunol; 2005 May; 174(9):5462-71. PubMed ID: 15843544 [TBL] [Abstract][Full Text] [Related]
59. [Changes of alveolar macrophage phagocytosis and TNF-alpha, IL-6 of rats with Pneumocystis pneumonia]. Lu ZM; Wang Y; Zhang XC; Tang HW Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Aug; 23(4):428-30. PubMed ID: 22164858 [TBL] [Abstract][Full Text] [Related]
60. IL-9 Deficiency Promotes Pulmonary Th17 Response in Murine Model of Li T; Rong HM; Zhang C; Zhai K; Tong ZH Front Immunol; 2018; 9():1118. PubMed ID: 29887863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]